Varsity Healthcare Partners Makes Growth Investment in Trialbee

TA Associates Completes Strategic Growth Investment in Vee Healthtek

November 18, 2024

Healthcare Services

TA Associates completed a strategic growth investment in Vee Healthtek to support the company's expansion of technology-enabled services for healthcare organizations. The partnership will help Vee Healthtek enhance its technology capabilities, expand offerings (organically and via M&A) across revenue cycle management, health information management, analytics, risk adjustment and claims management; financial terms were not disclosed.

Varsity Healthcare Partners Makes Strategic Growth Investment in Beghou Consulting

May 11, 2023

Healthcare Services

Varsity Healthcare Partners completed a strategic growth investment in Beghou Consulting, a global biopharmaceutical commercial-operations consulting firm headquartered in Evanston, Illinois. The investment will support Beghou’s continued expansion of analytics and proprietary technology capabilities; Jonathan Sandler will join Beghou’s board as part of the transaction.

Varsity Healthcare Partners Acquires VetEvolve from Align Capital Partners

October 16, 2023

Veterinary

Varsity Healthcare Partners completed a strategic growth investment to acquire VetEvolve, a Richmond, Virginia-based multi-location veterinary care platform. The transaction was a sale by Align Capital Partners; VetEvolve operates 32+ clinics across the Mid-Atlantic and employs over 600 team members, and VHP will partner with management to expand the platform into new geographies.

Enhanced Healthcare Partners Makes Growth Investment in Vytalize Health

April 13, 2022

Healthcare Services

Enhanced Healthcare Partners (EHP) has made a strategic growth investment in Vytalize Health to support the value-based primary care platform’s geographic expansion, care-delivery investments, and contracting with Medicare Advantage and commercial plans. The capital will be used to grow the team, expand into new markets, and increase penetration among existing partner primary care practices.

Ampersand Capital Partners Makes Growth Investment in VIVEbiotech

December 4, 2024

Biotechnology

Ampersand Capital Partners has made a growth equity investment in VIVEbiotech to support expansion of the company’s lentiviral vector development and GMP manufacturing capabilities in San Sebastián, Gipuzkoa, Spain. The investment will fund capacity growth and execution of VIVEbiotech’s pipeline of customer projects for cell and gene therapy developers, and industry veteran Dr. Stefan Beyer has been named Chairman.

LLR Partners Makes Growth Investment in TruTechnologies

May 28, 2025

Healthcare Services

LLR Partners has made a strategic growth investment in TruTechnologies, a provider of real-time clinical trial oversight and sample-management software. The capital will support TruTechnologies' product and commercial expansion; BofA served as exclusive financial advisor to TruTechnologies while Wachtell, Lipton, Rosen & Katz and DLA Piper served as legal advisors to the respective parties.